Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenase

Blood

Volumn 118, Issue 26, 2011, Pages 6971-6974

  Landfried, Karin ^a   Zhu, Wentao ^b   Waldhier, Magdalena C ^b   Schulz, Ute ^a   Ammer, Julia ^a   Holler, Barbara ^a   Wolff, Daniel ^a   Edinger, Matthias ^a   Peter, Katrin ^a   Kreutz, Marina ^a   Andreesen, Reinhard ^a   Oefner, Peter J ^b   Holler, Ernst ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; MESSENGER RNA; QUINOLINIC ACID; TRYPTOPHAN;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; URINE;

EID: 84455180409     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-357814     Document Type: Article

References (15)

1. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009; 373(9674):1550-1561.
2. Curti A, Trabanelli S, Salvestrini V, Baccarani M, Lemoli RM. The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. Blood. 2009;113(11):2394-2401.
3. Fallarino F, Grohmann U, Vacca C, et al. T cell apoptosis by kynurenines. Adv Exp Med Biol. 2003;527:183-190. (Pubitemid 38197643)
4. Beutelspacher SC, Tan PH, McClure MO, Larkin DF, Lechler RI, George AJ. Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant. 2006;6(6):1320-1330. (Pubitemid 44030315)
5. Matteoli G, Mazzini E, Iliev ID, et al. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut. 2010; 59(5):595-604.
6. Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol. 2010;185(6):3190-3198.
7. Jasperson LK, Bucher C, Panoskaltsis-Mortari A, Mellor AL, Munn DH, Blazar BR. Inducing the tryptophan catabolic pathway, indoleamine 2,3- dioxygenase (IDO), for suppression of graft-versus- host disease (GVHD) lethality. Blood. 2009;114(24):5062-5070.
8. Jasperson LK, Bucher C, Panoskaltsis-Mortari A, et al. Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality. Blood. 2008;111(6):3257-3265.
9. Steckel NK, Kuhn U, Beelen DW, Elmaagacli AH. Indoleamine 2,3-dioxygenase expression in patients with acute graft-versus-host disease after allogeneic stem cell transplantation and in pregnant women: association with the induction of allogeneic immune tolerance? Scand J Immunol. 2003;57(2):185-191. (Pubitemid 36232887)
10. Ratajczak P, Janin A, de Peffault LR, et al. IDO in human gut graft-vs-host disease [published online ahead of print, August 9, 2011]. Biol Blood Marrow Transplant. doi:10.1016/j.bbmt.2011.08.002.
11. Zhu W, Stevens AP, Dettmer K, et al. Quantitative profiling of tryptophan metabolites in serum, urine and cell culture supernatants by liquid chromatography- tandem mass spectrometry [published online ahead of print, October 8, 2011]. Anal Bioanal Chem. doi:10.1007/s0021-011-5436-y.
12. Meloni F, Giuliano S, Solari N, et al. Indoleamine 2,3-dioxygenase in lung allograft tolerance. J Heart Lung Transplant. 2009;28(11):1185- 1192.
13. Brandacher G, Cakar F, Winkler C, et al. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation. Kidney Int. 2007;71(1):60-67. (Pubitemid 44967735)
14. Debets JM, Leunissen KM, van Hooff HJ, van der Linden CJ, Buurman WA. Evidence of involvement of tumor necrosis factor in adverse reactions during treatment of kidney allograft rejection with antithymocyte globulin. Transplantation. 1989;47(3):487-492. (Pubitemid 19095644)
15. Pihusch R, Holler E, Muhlbayer D, et al. The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation. Bone Marrow Transplant. 2002;30(6):347-354. (Pubitemid 35203506)